SRES

Latest SEC Filings & News for SRES

1 most recent filing and news item mentioning SRES. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/SRES/news?limit=20"

Pull SRES filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Seres Therapeutics amends asset sale agreement with Nestlé to terminate future milestone payments

Seres Therapeutics and Société des Produits Nestlé S.A. amended their August 2024 asset purchase agreement to terminate Nestlé's obligations for second and third sales milestone payments and related interest accruals. The modification reduces Seres' potential future contingent pa

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.